Predictors of Relapse to Significant Alcohol Drinking after Liver Transplantation by Zamil Karim, Pongphob Intaraprasong, Charles H Scudamore, Siegfried R Erb, John G Soos, Elsie Cheung, Polly Cooper, Andrzej K Buzckowski, Stephen W Chung, Urs P Steinbrecher, Eric M Yoshida

“…BACKGROUND: End-stage alcoholic liver disease is common, with many of these patients referred for liver transplantation (LT). …”
Get full text

Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy by Heng Zhou, Guomin Xie, Yudi Mao, Ke Zhou, Ruixue Ren, Qihong Zhao, Hua Wang, Shi Yin

“…Liver ischemia-reperfusion injury (IRI) and regeneration deficiency are two major challenges for surgery patients with chronic liver disease. As a survival factor for hepatocytes, interleukin 22 (IL-22) plays an important role in hepatoprotection and the promotion of regeneration after hepatectomy. …”
Get full text

Metastatic Hepatocellular Carcinoma in a Patient with Crohn’s Disease Treated with Azathioprine and Infliximab: A Case Report and Literature Review by Kyle J. Fortinsky, Ali Alali, Khursheed Jeejeebhoy, Sandra Fischer, Morris Sherman, Scott Fung

“…The patient had no history of liver disease and a complete autoimmune and viral workup was unremarkable. …”
Get full text

SURGICAL RISK ASSESSMENT IN PATIENTS WITH LIVER CIRRHOSIS – A LITERATURE REVIEW by Elina Merashka

“…For this purpose, there are multiple classification and scoring systems for assessment – ​​Child-Pugh – Turcotte (CPT), Model of end-stage liver disease (MELD), Model of end-stage liver disease – Na (MELD – Na), Albumin – Bilirubin score (ALBI), each with specific indications for clinical use. …”
Get full text

The Liver That Cured Christmas: Case Report of Orthotopic Liver Transplant in a Patient with Hemophilia B by Jesse E. Harris, Jonathan L. Balk, Constance M. Mobley, Kirk Heyne

“…Herein, we discuss a case of a 39-year-old male with hemophilia B, who developed end-stage liver disease secondary to nonalcoholic steatohepatitis, that underwent orthotopic liver transplantation (OLT) as a curative means for his liver disease and coagulation disorder. …”
Get full text

Multiple Focal Nodular Hyperplasia and Steatohepatitis: Atypical Imaging Characteristics by Robert P Myers, Dónal Downey, Subrata Chakrabarti, Paul J Marotta

Get full text

Autoimmune Chronic Active Hepatitis (Lupoid Hepatitis) and Primary Sclerosing Cholangitis in Two Young Adult Females by Gerald Y. Minuk, Lloyd R. Sutherland, S. Chris Pappas, James K. Kelly, Sue E. Martin

Get full text

Vibrio vulnificus Septicemia after Handling Tilapia Species Fish: A Canadian Case Report and Review by Donald C Vinh, Samira Mubareka, Bunmi Fatoye, Pierre Plourde, Pamela Orr

“…Primary septicemia is often fatal, principally affecting persons with chronic liver disease.…”
Get full text

Innate Immune Cells in Liver Inflammation by Evaggelia Liaskou, Daisy V. Wilson, Ye H. Oo

Get full text

Posttransplant Metabolic Syndrome by M. Shadab Siddiqui, Richard K. Sterling

“…In addition to cardiovascular disease, the presence of MS is also closely associated with other comorbidities including nonalcoholic fatty liver disease (NAFLD). The prevalence of MS in patients with cirrhosis and end-stage liver disease is not well established and difficult to ascertain. …”
Get full text

Prevalence of Nonalcoholic Steatohepatitis and Associated Fibrosis Stages Among US Adults Using Imaging-Based vs Biomarker-Based Noninvasive Tests by Jesse Fishman, Tom O'Connell, Christina M. Parrinello, Jonathan J. Woolley, Eric Bercaw, Michael R. Charlton

“…**Introduction:** Nonalcoholic fatty liver disease (NAFLD) is believed to be the most common chronic liver disease worldwide. …”
Get full text

Complementary and Alternative Medicine Use by Patients Chronically Infected with Hepatitis C Virus by Colin P White, Gerilynn Hirsch, Sunil Patel, Fatin Adams, Kevork M Peltekian

“…The use of CAM is also popular in patients with chronic liver disease but is not well documented. The extent of use of CAM in chronic hepatitis C virus (HCV) infected patients was determined, and the demographic and clinical data between users and nonusers of CAM was compared.…”
Get full text

A Meta-Analysis of Nutritional Supplementation for Management of Hospitalized Alcoholic Hepatitis by Ramy Antar, Phil Wong, Peter Ghali

“…BACKGROUND: Alcoholic liver disease (ALD) is associated with a high risk of morbidity and mortality. …”
Get full text

Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes by Amedeo Lonardo

“…Nonalcoholic fatty liver disease (NAFLD), its more rapidly progressive steatohepatitic variant [nonalcoholic steatohepatitis, (NASH)], and the recently defined metabolic dysfunction-associated fatty liver disease (MAFLD) may be collectively alluded to as “metabolic fatty liver syndromes” (MFLS). …”
Get full text

Management of Hepatic Encephalopathy by G. Wright, A. Chattree, R. Jalan

“…Hepatic encephalopathy (HE), the neuropsychiatric presentation of liver disease, is associated with high morbidity and mortality. …”
Get full text

Motion – The Available Treatments for Hepatitis C Are Cost Effective: Arguments against the Motion by W Ray Kim

“…Available cohortbased studies suggest that only a relative minority of patients develop significant liver disease, such as cirrhosis and/or hepatocellular carcinoma. …”
Get full text

Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis by Hiroki Nishikawa, Yukio Osaki

“…Chronic hepatitis C virus infection is the major cause of chronic liver disease. Liver cirrhosis (LC) results from different mechanisms of liver injury that lead to necroinflammation and fibrosis. …”
Get full text

A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD by Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty

“…Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the western world with prevalence of 20–33%. …”
Get full text

An Overview of In Vitro Models of Alcohol‐Related Hepatocellular Carcinoma by Anoïsia Courtois, Sophie Gérard, Damien Esparteiro, Eric Nguyen‐Khac, Ingrid Marcq, Grégory Fouquet

“…ABSTRACT Background Chronic and excessive alcohol consumption is the leading cause of death due to chronic liver disease. Alcohol‐related liver disease (ALD) encompasses a broad spectrum of clinical and pathological features, ranging from asymptomatic and reversible pathologies to hepatocellular carcinoma (HCC), a highly prevalent and deadly liver cancer. …”
Get full text

Current Treatment Approaches to HCC with a Special Consideration to Transplantation by N. Bhardwaj, M. T. P. R. Perera, M. A. Silva

“…Resectable patients with early HCC and underlying liver disease are however increasingly being considered for transplantation because of potential for better disease-free survival and resolution of underlying liver disease, although this approach is limited by the availability of donor livers, especially in resectable patients. …”
Get full text